Myriad Genetics (MYGN) Slight Miss on Revenue; Beats on Earnings

By Trader Mark
04 May 2009 @ 06:31 pm EDT

As always, you can tell a lot from the stock price action ahead of earnings because in the nearly SEC free Wild Wild West atmosphere "those in the know" act before you will. Myriad Genetics (MYGN) has been weak for the past two weeks, falling below the 50 day moving average 2 weeks ago on 3 days of high volume selling (see those 3 big red bars in the volume column in late April?). Ding ding - we have a winner; the "important people" were exiting the stage starting in the $44s....

International Business Times

E-Newsletters

We value your privacy. Your email address will not be shared.

Home
World
US
Economy
Companies
Tech
Science
Global Markets
Education
Real Estate
Forex
Commodities
Gold & Silver Matters
More Sections
Fashion
Auto
Travel
Health
Law
Entertainment
Sports
Luxury
Art
Books
Tech & Trend
Tools & Features
Topics
Blogs
Market Data
Stock Watch List
Investment Calculator
Financial Glossary
Broker Center
World Business Headlines
Updates
RSS Feeds
IBTimes on Twitter
IBTimes on Facebook
E-Newsletters
Services
Forex Newsfeed
Research
Press Release
About IBTimes
News Licensing
Media Kit
Advertise with Us
About IBTimes
Contact Us
Terms of Service
Privacy Policy